Xspray Pharma AB (publ)
SSE:XSPRAY.ST
44 (SEK) • At close February 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) SEK.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||
| Net Income
| -179.667 | -133.073 | -97.953 | -53.457 | -46.564 | -23.217 | -13.278 | -4.059 | -12.088 |
| Depreciation & Amortization
| 9.194 | 9.533 | 8.87 | 7.689 | 4.803 | 4.101 | 1.166 | 0.665 | 0.608 |
| Deferred Income Tax
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change In Working Capital
| -31.581 | -3.575 | 4.375 | -1.315 | 8.894 | 1.251 | 0.993 | 1.687 | -1.279 |
| Accounts Receivables
| -4.109 | -2.942 | -5.712 | 2.479 | -1.963 | -3.765 | 0.628 | 0.169 | -0.174 |
| Inventory
| -35.229 | 0.001 | -0.01 | 0.004 | -0.011 | 0 | 0 | 0 | 0 |
| Accounts Payables
| 7.757 | -0.633 | 10.087 | -3.794 | 10.857 | 4.89 | -1.453 | 0 | 0 |
| Other Working Capital
| 0.008 | -0.001 | 0.01 | -0.004 | 0.011 | 0.126 | 1.818 | -2.003 | -1.491 |
| Other Non Cash Items
| -1.221 | 16.936 | 33.101 | -0.709 | -1.37 | 0.119 | 0.079 | -0.037 | -0.205 |
| Operating Cash Flow
| -203.275 | -110.179 | -51.607 | -47.792 | -34.237 | -17.746 | -11.04 | -1.744 | -12.964 |
| Investing Activities: | |||||||||
| Investments In Property Plant And Equipment
| -54.103 | -128.286 | -95.964 | -97.211 | -91.994 | -46.958 | -24.635 | -19.61 | -0.214 |
| Acquisitions Net
| 0 | 0 | 0 | 0.383 | 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| 0 | 0 | 0 | 0 | 0 | -0.05 | 0 | 0 | -0.001 |
| Sales Maturities Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| -11.773 | -7.059 | -9.854 | -3.656 | -0.069 | -32.015 | -21.865 | -19.324 | -0.214 |
| Investing Cash Flow
| -65.876 | -135.345 | -105.818 | -96.828 | -91.994 | -47.008 | -24.635 | -19.61 | -0.215 |
| Financing Activities: | |||||||||
| Debt Repayment
| -45 | -2.128 | -2.154 | -0.936 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued
| 272.245 | 100.813 | 105.916 | 261.544 | 114.949 | 170.458 | 122.384 | 0 | 0 |
| Common Stock Repurchased
| 0 | -0.052 | -0.054 | -0.074 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 88.349 | -2.644 | 105.862 | 0.821 | -0.112 | 170.458 | 122.384 | 38.307 | 22.551 |
| Financing Cash Flow
| 315.594 | 93.809 | 103.708 | 260.345 | 114.837 | 170.458 | 122.384 | 38.307 | 22.551 |
| Other Information: | |||||||||
| Effect Of Forex Changes On Cash
| -0.306 | 0 | 0 | 0.001 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| 46.137 | -151.715 | -53.717 | 115.726 | -11.394 | 105.704 | 86.709 | 16.953 | 9.572 |
| Cash At End Of Period
| 166.303 | 120.166 | 271.881 | 325.598 | 209.872 | 221.216 | 115.512 | 28.803 | 11.85 |